Correlation Between Hansa Biopharma and Lipum AB

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Hansa Biopharma and Lipum AB at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Hansa Biopharma and Lipum AB into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Hansa Biopharma AB and Lipum AB, you can compare the effects of market volatilities on Hansa Biopharma and Lipum AB and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Hansa Biopharma with a short position of Lipum AB. Check out your portfolio center. Please also check ongoing floating volatility patterns of Hansa Biopharma and Lipum AB.

Diversification Opportunities for Hansa Biopharma and Lipum AB

-0.79
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Hansa and Lipum is -0.79. Overlapping area represents the amount of risk that can be diversified away by holding Hansa Biopharma AB and Lipum AB in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Lipum AB and Hansa Biopharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Hansa Biopharma AB are associated (or correlated) with Lipum AB. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Lipum AB has no effect on the direction of Hansa Biopharma i.e., Hansa Biopharma and Lipum AB go up and down completely randomly.

Pair Corralation between Hansa Biopharma and Lipum AB

Assuming the 90 days trading horizon Hansa Biopharma AB is expected to under-perform the Lipum AB. In addition to that, Hansa Biopharma is 1.2 times more volatile than Lipum AB. It trades about -0.28 of its total potential returns per unit of risk. Lipum AB is currently generating about 0.31 per unit of volatility. If you would invest  1,410  in Lipum AB on August 28, 2024 and sell it today you would earn a total of  280.00  from holding Lipum AB or generate 19.86% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Hansa Biopharma AB  vs.  Lipum AB

 Performance 
       Timeline  
Hansa Biopharma AB 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Hansa Biopharma AB has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in December 2024. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.
Lipum AB 

Risk-Adjusted Performance

9 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Lipum AB are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively unfluctuating basic indicators, Lipum AB unveiled solid returns over the last few months and may actually be approaching a breakup point.

Hansa Biopharma and Lipum AB Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Hansa Biopharma and Lipum AB

The main advantage of trading using opposite Hansa Biopharma and Lipum AB positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Hansa Biopharma position performs unexpectedly, Lipum AB can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Lipum AB will offset losses from the drop in Lipum AB's long position.
The idea behind Hansa Biopharma AB and Lipum AB pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.

Other Complementary Tools

Commodity Directory
Find actively traded commodities issued by global exchanges
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences